Jordan, Roberta I; Mulvey, Matthew R; Bennett, Michael I
This
review summarizes recent randomised controlled trials (RCTs) evaluating the use
of gabapentinoids for tumour-related and treatment-related pain. Many of the
studies included were limited by small sample size, lack of blinding, and
inadequate follow-up. The authors therefore conclude that more and better quality studies are required but that gabapentinoids may offer benefits to cancer patients with pain, but that careful
titration and monitoring of adverse effects is necessary.